Banach Maciej, Fras Zlatko, Gaita Dan, Pecin Ivan, Bajraktari Gani, Bjelakovic Bojko, Bytyci Ibadete, Ceska Richard, Djuric Dragan, Gil Robert J, Jozwiak Jacek, Kubilius Raimondas, Latkovskis Gustavs, Mitchenko Olena, Paragh Gyorgy, Pella Daniel, Petrulioniene Zaneta, Postadzhiyan Arman, Stoian Anca Pantea, Szymański Piotr, Viigimaa Margus, Vinereanu Dragos, Vohnout Branislav, Vrablik Michal, Reiner Zeljko
Faculty of Medicine, John Paul II Catholic University of Lublin, Lublin, Poland.
Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland.
Glob Heart. 2025 Nov 14;20(1):103. doi: 10.5334/gh.1491. eCollection 2025.
Cardiovascular diseases (CVDs) remain a leading global cause of mortality and disability, with significant disparities observed across countries. This is particularly true in Central and Eastern Europe (CEE), where populations are primarily at high and very high CVD risk. Highlighting modifiable risk factors underscores the urgent need for effective prevention programs. This paper introduces the European Program for Prevention (EPP), an initiative by the International Lipid Expert Panel (ILEP), designed to address these challenges. The EPP aims to enhance awareness and knowledge of validated preventive healthcare solutions implemented in CEE countries, showcase the region's potential for innovative strategies, and evaluate the adaptability of successful programs for broader implementation. The EPP strongly supports the EU Cardiovascular Health Plan, as well as initiatives by the World Heart Federation (WHF) and World Health Organization (WHO), by promoting best practices, early detection, integrated prevention frameworks, training, cross-border cooperation, and policy development. It advocates shifting healthcare priorities towards pre-disease prevention, thus reducing reliance on resource-intensive treatments. The program proposes an optimal CVD prevention system that includes mandatory health education, screening programs for familial hypercholesterolemia and universal Lp(a) screening, and comprehensive check-ups, notably integrated, comprehensive care programs. By leveraging existing validated programs and fostering collaboration, the EPP seeks to reduce the burden of CVD, improve outcomes, and promote cardiovascular health across Europe and beyond.
心血管疾病（CVDs）仍然是全球主要的死亡和残疾原因，各国之间存在显著差异。在中欧和东欧（CEE）尤其如此，那里的人群主要处于高心血管疾病风险和极高心血管疾病风险之中。强调可改变的风险因素凸显了制定有效预防计划的迫切需求。本文介绍了欧洲预防计划（EPP），这是国际脂质专家小组（ILEP）发起的一项倡议，旨在应对这些挑战。EPP旨在提高人们对中东欧国家实施的经过验证的预防性医疗保健解决方案的认识和了解，展示该地区创新战略的潜力，并评估成功项目在更广泛实施中的适应性。EPP通过推广最佳实践、早期检测、综合预防框架、培训、跨境合作和政策制定，大力支持欧盟心血管健康计划以及世界心脏联合会（WHF）和世界卫生组织（WHO）的倡议。它主张将医疗保健重点转向疾病前期预防，从而减少对资源密集型治疗的依赖。该计划提出了一个最佳的心血管疾病预防系统，包括强制性健康教育、家族性高胆固醇血症筛查项目和普遍的脂蛋白（a）筛查，以及全面体检，特别是综合、全面的护理项目。通过利用现有的经过验证的项目并促进合作，EPP旨在减轻心血管疾病负担，改善治疗效果，并在欧洲及其他地区促进心血管健康。
